3,360
Participants
Start Date
October 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
October 31, 2013
Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation
0.1mL, Intradermal
Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone® Intradermal
0.1mL, Intradermal
Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone Intradermal
0.1mL, Intradermal
Binghamton
Rochester
Rochester
Allentown
Bensalem
Mt. Pleasant
Melbourne
Coral Gables
South Miami
Pinellas Park
Hoover
Huntsville
Iowa City
Marshfield
Dakota Dunes
St Louis
Kansas City
Springfield
Overland Park
Wichita
Omaha
Fort Worth
Fort Worth
San Angelo
Austin
Boise
West Jordan
Salt Lake City
Salt Lake City
Phoenix
Mesa
Chandler
Tucson
Chula Vista
San Diego
Sacramento
Milford
Warwick
Sanofi Pasteur, a Sanofi Company
INDUSTRY